Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amy Sperling"'
Autor:
Adam S. Zayac, Andrew M. Evens, Alexey Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie, Catherine Wei, Seo-Hyun Kim, Seema Naik, Suchitra Sundaram, Nishitha Reddy, Umar Farooq, Vaishalee P. Kenkre, Narendranath Epperla, Kristie A. Blum, Nadia Khan, Daulath Singh, Juan P. Alderuccio, Amandeep Godara, Maryam Sarraf Yazdy, Catherine Diefenbach, Emma Rabinovich, Gaurav Varma, Reem Karmali, Yusra Shao, Asaad Trabolsi, Madelyn Burkart, Peter Martin, Sarah Stettner, Ayushi Chauhan, Yun Kyong Choi, Allandria Straker-Edwards, Andreas Klein, Michael C. Churnetski, Kirsten M. Boughan, Stephanie Berg, Bradley M. Haverkos, Victor M. Orellana-Noia, Christopher D'Angelo, David A. Bond, Seth M. Maliske, Ryan Vaca, Gabriella Magarelli, Amy Sperling, Max J. Gordon, Kevin A. David, Malvi Savani, Paolo Caimi, Manali Kamdar, Matthew A Lunning, Neil Palmisiano, Parameswaran Venugopal, Craig A. Portell, Veronika Bachanova, Tycel Phillips, Izidore S. Lossos, Adam J. Olszewski
Publikováno v:
Haematologica, Vol 106, Iss 7 (2021)
Central nervous system (CNS) involvement in Burkitt lymphoma (BL) poses a major therapeutic challenge, and the relative ability of contemporary regimens to treat CNS involvement remains uncertain. We described prognostic significance of CNS involveme
Externí odkaz:
https://doaj.org/article/7ae0d22933a943c387290b9e2d6a94f3
Autor:
Craig A. Portell, Seo-Hyun Kim, Catherine Wei, Neil Palmisiano, Catherine Diefenbach, Manali Kamdar, Madelyn Burkart, Nadia Khan, Seth M. Maliske, Izidore S. Lossos, Andreas K. Klein, Paolo Caimi, Narendranath Epperla, Amandeep Godara, Alexey V. Danilov, Victor M. Orellana-Noia, Max J. Gordon, Adam Zayac, Maryam Sarraf Yazdy, Allandria Straker-Edwards, Michael C. Churnetski, Ayushi Chauhan, Umar Farooq, Deepa Jagadeesh, Daulath Singh, Matthew A. Lunning, Suchitra Sundaram, Sarah Stettner, Kirsten M Boughan, Lori A. Leslie, Yusra F. Shao, Peter Martin, Amy Sperling, Stephen D. Smith, Reem Karmali, Bradley M. Haverkos, Parameswaran Venugopal, Veronika Bachanova, Tycel Phillips, Yun Kyong Choi, Malvi Savani, Seema Naik, Gaurav Varma, Vaishalee P. Kenkre, Gabriella Magarelli, Ryan Vaca, Asaad Trabolsi, Andrew M. Evens, Juan Pablo Alderuccio, Emma Rabinovich, Christopher D'Angelo, Nishitha Reddy, Adam J. Olszewski, Kristie A. Blum, Stephanie Berg, David A. Bond, Kevin A. David
Publikováno v:
Haematologica. 106:1932-1942
Central nervous system (CNS) involvement in Burkitt lymphoma (BL) poses a major therapeutic challenge, and the relative ability of contemporary regimens to treat CNS involvement remains uncertain. We described prognostic significance of CNS involveme
Autor:
Allandria Straker-Edwards, Catherine Wei, Paolo Caimi, Andreas K. Klein, Michael C. Churnetski, Suchitra Sundaram, Deepa Jagadeesh, Andrew M. Evens, Neil Palmisiano, Catherine Diefenbach, Matthew A. Lunning, Kevin A. David, Agrima Mian, Adam J. Olszewski, Parameswaran Venugopal, Manali Kamdar, Nadia Khan, Albert Ren, Veronika Bachanova, Umar Farooq, Vaishalee P. Kenkre, Craig A. Portell, Nishitha Reddy, Tatyana Feldman, Victor M. Orellana-Noia, Alexey V. Danilov, Gaurav Varma, Jeremy Ramdial, Seema Naik, Yun Kyong Choi, Ayushi Chauhan, Tycel Phillips, Kristie A. Blum, Madelyn Burkart, Andrzej Stadnik, Reem Karmali, Stephen D. Smith, Ryan Vaca, Christopher D'Angelo, Daniel Rector, Brad M. Haverkos, Narendranath Epperla, Amy Sperling, Juan Pablo Alderuccio, Yong Lin, Seth M. Maliske, Stephanie Berg, Izidore S. Lossos, Malvi Savani, Seo-Hyun Kim, Maryam Sarraf Yazdy, Amandeep Godara, David A. Bond, Peter Martin, Adam Zayac, Scott E. Smith, Emma Rabinovich, Kirsten M Boughan
Publikováno v:
Blood. 137(3)
We examined adults with untreated Burkitt lymphoma (BL) from 2009 to 2018 across 30 US cancer centers. Factors associated with progression-free survival (PFS) and overall survival (OS) were evaluated in univariate and multivariate Cox models. Among 6
Autor:
Parameswaran Venugopal, Graham P. Collins, Yun Kyong Choi, Suchitra Sundaram, Frank A. Post, Peter Martin, Victor M. Orellana-Noia, Juan Pablo Alderuccio, Umar Farooq, Andrew M. Evens, Ayushi Chauhan, Vaishalee P. Kenkre, Catherine Diefenbach, Kirsten M Boughan, Andrzej Stadnik, Albert Ren, Tatyana Feldman, Allandria Straker-Edwards, Stephen D. Smith, Madelyn Burkart, Alexey V. Danilov, Scott E. Smith, Emma Rabinovich, Reem Karmali, Catherine Zhu, Adam Zayac, Bradley M. Haverkos, Silvia Montoto, Amy Sperling, Narendranath Epperla, Adam J. Olszewski, Yong Lin, Manali Kamdar, Seth M. Maliske, Nadia Khan, Izidore S. Lossos, Catherine Wei, Maryam Sarraf Yazdy, Stephanie Berg, Paolo Caimi, Amandeep Godara, David A. Bond, Craig A. Portell, Seo-Hyun Kim, Gaurav Varma, Shireen Kassam, Michael C. Churnetski, Mark Bower, Andreas K. Klein, Deepa Jagadeesh, Kate Cwynarski, Ryan Vaca, Daniel Rector, Alessia Dalla Pria, Agrima Mian, Nishitha Reddy, Seema Naik, Kristie A. Blum, Christopher D'Angelo
Publikováno v:
Blood. 136:49-50
Introduction: There are few data about prognostication and outcomes in patients (pts) with HIV-BL treated in the cART era. Optimal treatment strategies to minimize treatment-related mortality (TRM) remain unclear and current recommendations are based
Autor:
Adam J. Olszewski, Madelyn Burkart, Jeremy Ramdial, Agrima Mian, Yong Lin, Adam Zayac, Andreas K. Klein, Seth M. Maliske, Izidore S. Lossos, Narendranath Epperla, Amandeep Godara, Maryam Sarraf Yazdy, Christopher D'Angelo, Kirsten M Boughan, Seo-Hyun Kim, Parameswaran Venugopal, Emma Rabinovich, Reem Karmali, Scott E. Smith, Seema Naik, Kevin A. David, Vaishalee P. Kenkre, Gaurav Varma, Nishitha Reddy, Michael C. Churnetski, Deepa Jagadeesh, Tatyana Feldman, Suchitra Sundaram, Yun Kyong Choi, Andrew M. Evens, Catherine Diefenbach, Kristie A. Blum, Victor M. Orellana-Noia, Alexey V. Danilov, Andrzej Stadnik, Ayushi Chauhan, Craig A. Portell, Peter Martin, Brad M. Haverkos, Amy Sperling, Umar Farooq, Stephen D. Smith, Ryan Vaca, Daniel Rector, Juan Pablo Alderuccio, Stephanie Berg, Allandria Straker-Edwards, David A. Bond, Manali Kamdar, Nadia Khan, Catherine Wei, Paolo Caimi, Albert Ren
Publikováno v:
Blood. 134:397-397
Introduction: Historically, outcomes for BL have improved in adults using dose intensive chemotherapy regimens and early CNS prophylaxis. More recent data using a less intensive regimen, DA-EPOCH, have been reported. We analyzed detailed patient (pt)
Autor:
Catherine Wei, Yun Kyong Choi, Stephanie Berg, Andreas K. Klein, Paolo Caimi, Seo-Hyun Kim, Narendranath Epperla, Allandria Straker-Edwards, Victor M. Orellana-Noia, Seth M. Maliske, Ayushi Chauhan, Adam J. Olszewski, Izidore S. Lossos, Max J. Gordon, Brad M. Haverkos, David A. Bond, Maryam Sarraf Yazdy, Amy Sperling, Nishitha Reddy, Umar Farooq, Amandeep Godara, Peter Martin, Andrzej Stadnik, Kevin A. David, Seema Naik, Kirsten M Boughan, Gabriela Magarelli, Gaurav Varma, Kristie A. Blum, Suchitra Sundaram, Vaishalee P. Kenkre, Ryan Vaca, Andrew M. Evens, Reem Karmali, Catherine Diefenbach, Madelyn Burkart, Stephen D. Smith, Emma Rabinovich, Christopher D'Angelo, Parameswaran Venugopal, Asaad Trabolsi, Juan Pablo Alderuccio, Michael C. Churnetski, Adam Zayac, Deepa Jagadeesh, Manali Kamdar, Nadia Khan, Lori A. Leslie, Yusra F. Shao, Daulath Singh, Sarah Stettner, Craig A. Portell
Publikováno v:
Blood. 134:402-402
Background: BL is associated with a high risk of primary or secondary CNS involvement, warranting intrathecal (IT) and/or systemic therapy that penetrates the blood-brain barrier (BBB). The lower-intensity DA-EPOCH-R regimen has recently shown high s